References

10.1186/s12916-017-0779-7

10.1186/s12916-017-0779-7 · External reference

10.1016/s1474-4422(09)70236-4

10.1016/s1474-4422(09)70236-4 · External reference

Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association

10.1161/str.0000000000000430 · 2023 · External reference

10.1161/circresaha.122.319951

10.1161/circresaha.122.319951 · External reference

10.1001/jama.2014.13806

10.1001/jama.2014.13806 · External reference

Risk factors for dementia and cognitive impairment within 5 years after stroke: a prospective multicentre cohort study

10.1016/j.lanepe.2025.101428 · 2025 · External reference

10.1016/j.jalz.2018.07.219

10.1016/j.jalz.2018.07.219 · External reference

10.1016/j.arr.2022.101814

10.1016/j.arr.2022.101814 · External reference

10.1002/alz.13744

10.1002/alz.13744 · External reference

Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke

10.3233/jad-131580 · 2014 · External reference

10.1161/strokeaha.112.667618

10.1161/strokeaha.112.667618 · External reference

10.1159/000443649

10.1159/000443649 · External reference

10.1161/strokeaha.119.026829

10.1161/strokeaha.119.026829 · External reference

10.1002/alz.13104

10.1002/alz.13104 · External reference

Incidence of post-stroke cognitive impairment in patients with first-ever ischemic stroke: a multicenter cross-sectional study in China

2023 · External reference

10.1177/17474930261417825

10.1177/17474930261417825 · External reference

China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design

10.1136/svn-2020-000828 · 2021 · External reference

Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial

10.1136/bmj-2023-076448 · 2023 · External reference

Cognitive impairment in acute ischemic stroke patients with early versus delayed antihypertensive treatment: a prespecified analysis of CATIS-2 trial

10.1177/17474930251401203 · 2026 · External reference

10.1161/strokeaha.123.044698

10.1161/strokeaha.123.044698 · External reference

10.1161/strokeaha.115.010418

10.1161/strokeaha.115.010418 · External reference

10.1016/s1474-4422(18)30442-3

10.1016/s1474-4422(18)30442-3 · External reference

10.1007/s00415-019-09442-6

10.1007/s00415-019-09442-6 · External reference

Lifespan exposures to rural–urban conditions and later‐life cognitive function

10.1002/alz.70267 · 2025 · External reference

10.1016/j.inpsyc.2025.100165

10.1016/j.inpsyc.2025.100165 · External reference

10.1016/j.jns.2014.08.042

10.1016/j.jns.2014.08.042 · External reference

Association and interaction of blood homocysteine and p‐tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer’s disease

10.1002/alz.70465 · 2025 · External reference

10.1161/strokeaha.118.020827

10.1161/strokeaha.118.020827 · External reference

Post-stroke cognitive impairment on the Mini-Mental State Examination primarily relates to left middle cerebral artery infarcts

10.1177/1747493020984552 · 2021 · External reference

Incremental value of stroke-induced structural disconnection in predicting global cognitive impairment after stroke

10.1161/strokeaha.122.042127 · 2023 · External reference

Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: a multicenter study in 1568 stroke patients

10.1177/17474930241252530 · 2024 · External reference

Cognitive implications and associated transcriptomic signatures of distinct regional iron depositions in cerebral small vessel disease

10.1002/alz.70196 · 2025 · External reference

10.1136/jnnp-2016-313914

10.1136/jnnp-2016-313914 · External reference

10.1111/ene.14910

10.1111/ene.14910 · External reference

10.1007/s00415-015-7776-6

10.1007/s00415-015-7776-6 · External reference